Intuitive Surgical Inc. (ISRG)
NASDAQ: ISRG
· Real-Time Price · USD
552.31
-3.44 (-0.62%)
At close: May 30, 2025, 3:59 PM
552.00
-0.06%
After-hours: May 30, 2025, 05:29 PM EDT
Intuitive Surgical Revenue Breakdown
Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
---|---|---|---|---|---|---|---|
Instruments and Accessories Revenue | 5.08B | 4.28B | 3.52B | 3.1B | 2.46B | 2.41B | 1.96B |
Instruments and Accessories Revenue Growth | +18.76% | +21.57% | +13.46% | +26.26% | +1.97% | +22.74% | n/a |
Services Revenue | 1.31B | 1.17B | 1.02B | 916.2M | 723.8M | 724.2M | 635.1M |
Services Revenue Growth | +11.93% | +14.02% | +11.79% | +26.58% | -0.06% | +14.03% | n/a |
Systems Revenue | 1.97B | 1.68B | 1.68B | 1.69B | 1.18B | 1.35B | 1.13B |
Systems Revenue Growth | +17.04% | -0.02% | -0.79% | +43.64% | -12.42% | +19.43% | n/a |
Operating Expense Breakdown
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 563.4M | 612.6M | 510.6M | 525.3M | 491.5M | 567.1M | 452M | 464.3M | 480.5M | 494.3M | 436.1M | 418.4M | 391.1M | 427M | 363.3M | 350.2M | 326M | 330.2M | 298.9M | 279.1M | 308.1M | 341.8M | 284M | 279.2M | 273.4M | 283.8M | 221.4M | 259.8M | 221.6M | 219.2M | 204.8M | 185.8M | 201.1M | 193.7M | 168M | 170.8M | 172.8M | 160.3M | 154.9M | 163.3M | 162M |
Selling, General, and Administrative Revenue Growth | -8.03% | +19.98% | -2.80% | +6.88% | -13.33% | +25.46% | -2.65% | -3.37% | -2.79% | +13.35% | +4.23% | +6.98% | -8.41% | +17.53% | +3.74% | +7.42% | -1.27% | +10.47% | +7.09% | -9.41% | -9.86% | +20.35% | +1.72% | +2.12% | -3.66% | +28.18% | -14.78% | +17.24% | +1.09% | +7.03% | +10.23% | -7.61% | +3.82% | +15.30% | -1.64% | -1.16% | +7.80% | +3.49% | -5.14% | +0.80% | n/a |
Research and Development Revenue | 316.2M | 294.7M | 286M | 280.1M | 284.5M | 260.1M | 249.4M | 244.4M | 244.9M | 244.1M | 217.1M | 207.3M | 210.5M | 183.4M | 165.5M | 162.3M | 159.8M | 149.8M | 155M | 143.2M | 147.1M | 156.6M | 135.9M | 120.8M | 144M | 119.9M | 107.6M | 95.1M | 95.5M | 87.1M | 83.4M | 84.6M | 73.5M | 69.1M | 62.6M | 54.7M | 53.2M | 52.6M | 51M | 49.4M | 44.4M |
Research and Development Revenue Growth | +7.30% | +3.04% | +2.11% | -1.55% | +9.38% | +4.29% | +2.05% | -0.20% | +0.33% | +12.44% | +4.73% | -1.52% | +14.78% | +10.82% | +1.97% | +1.56% | +6.68% | -3.35% | +8.24% | -2.65% | -6.07% | +15.23% | +12.50% | -16.11% | +20.10% | +11.43% | +13.14% | -0.42% | +9.64% | +4.44% | -1.42% | +15.10% | +6.37% | +10.38% | +14.44% | +2.82% | +1.14% | +3.14% | +3.24% | +11.26% | n/a |